loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 20234 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Bachem AG

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Bachem AG (1)

    filter

    01 ETOMIDATE (1)

    filter

    01 Switzerland (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BACHEM SA

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
    Contact Supplier Contact Supplier
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ETOMIDATE

    PDF Supplier PDF
    URL Supplier Web Content
    20234
    Active
    2007-01-29
    Complete
    2014-10-16
    2014-10-14
    II
    Bachem company banner

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 20234 of Bachem Sa

    Looking for Drug Master Files (DMF) for 20234 of Bachem Sa 1

    20

    Bachem Sa, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    One of their notable products is ETOMIDATE, with a corresponding US DMF Number 20234.

    Remarkably, this DMF maintains an Active status since its submission on January 29, 2007, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of October 16, 2014, and payment made on October 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY